Tevogen Bio Holdings (TVGN) Receivables - Other (2023 - 2026)
Tevogen Bio Holdings (TVGN) reported Receivables - Other of $158819.0 for Q1 2026, little changed on a YoY basis from $158819.0 in Q1 2025, and little changed quarter-over-quarter from $158819.0 in Q4 2025.
Tevogen Bio Holdings (TVGN) Receivables - Other (2023 - 2026) Analysis & Trends
Tevogen Bio Holdings has reported Receivables - Other for 4 years, with the latest figure at $158819.0 in Q1 2026.
- For the quarter ending Q1 2026, Receivables - Other changed 0.0% year-over-year to $158819.0; the trailing twelve-month figure through Mar 2026 stood at $158819.0 (changed 0.0% YoY), and the FY2025 full-year result was $158819.0, changed 0.0% from the prior year.
- Receivables - Other for Q1 2026 stood at $158819.0, roughly flat from $158819.0 in the prior quarter.
- The five-year high for Receivables - Other was $344500.0 in Q4 2023, with the low at $158819.0 in Q1 2024.
- Historically, Receivables - Other has averaged $177387.1 across 4 years, with a median of $158819.0 in 2024.
- Annual changes were most pronounced in 2024 — Receivables - Other sank 53.9% — and 2025, when it changed 0.0%.
- Tevogen Bio Holdings' Receivables - Other stood at $344500.0 in 2023, then slumped by 53.9% to $158819.0 in 2024, then changed by 0.0% to $158819.0 in 2025, then changed by 0.0% to $158819.0 in 2026.
- The last three Receivables - Other figures came in at $158819.0 (Q1 2026), $158819.0 (Q4 2025), and $158819.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Tevogen Bio Holdings | 173.69 Mn | 173.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 158,819.00 |
| Mar 31, 2026 | 158,819.00 |
| Dec 31, 2025 | 158,819.00 |
| Dec 31, 2025 | 158,819.00 |
| Sep 30, 2025 | 158,819.00 |
| Sep 30, 2025 | 158,819.00 |
| Jun 30, 2025 | 158,819.00 |
| Jun 30, 2025 | 158,819.00 |
| Mar 31, 2025 | 158,819.00 |
| Mar 31, 2025 | 158,819.00 |
| Dec 31, 2024 | 158,819.00 |
| Dec 31, 2024 | 158,819.00 |
| Sep 30, 2024 | 158,819.00 |
| Sep 30, 2024 | 158,819.00 |
| Jun 30, 2024 | 158,819.00 |
| Jun 30, 2024 | 158,819.00 |
| Mar 31, 2024 | 158,819.00 |
| Mar 31, 2024 | 158,819.00 |
| Dec 31, 2023 | 344,500.00 |
| Dec 31, 2023 | 344,500.00 |